Literature DB >> 27140937

Genetic variants associated with physical and mental characteristics of the elite athletes in the Polish population.

B Peplonska1, J G Adamczyk2,3, M Siewierski2, K Safranow4, A Maruszak1,5, H Sozanski2, A K Gajewski2, C Zekanowski2.   

Abstract

The aim of the study was to assess whether selected genetic variants are associated with elite athlete performance in a group of 413 elite athletes and 451 sedentary controls. Polymorphisms in ACE, ACTN3, AGT, NRF-2, PGC1A, PPARG, and TFAM implicated in physical performance traits were analyzed. Additionally, polymorphisms in CHRNB3 and FAAH coding for proteins modulating activity of brain's emotion centers were included. The results of univariate analyses indicated that the elite athletic performance is associated with four polymorphisms: ACE (rs4341, P = 0.0095), NRF-2 (rs12594956, P = 0.011), TFAM (rs2306604, P = 0.049), and FAAH (rs324420, P = 0.0041). The multivariate analysis adjusted for age and gender confirmed this association. The higher number of ACE D alleles (P = 0.0021) and the presence of NRF-2 rs12594956 A allele (P = 0.0067) are positive predictors, whereas TFAM rs2306604 GG genotype (P = 0.031) and FAAH rs324420 AA genotype (P = 0.0084) negatively affect the elite athletic performance. The CHRNB3 variant (rs4950, G allele) is significantly more frequent in the endurance athletes compared with the power ones (P = 0.025). Multivariate analysis demonstrated that the presence of rs4950 G allele contributes to endurance performance (P = 0.0047). Our results suggest that genetic inheritance of psychological traits should be taken into consideration while trying to decipher a genetic profile of top athletic performance.
© 2016 The Authors. Scandinavian Journal of Medicine & Science in Sports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Polymorphisms; endurance athletes; power athletes; psychological traits

Mesh:

Substances:

Year:  2016        PMID: 27140937     DOI: 10.1111/sms.12687

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  7 in total

1.  Association of PPARGC1A Gly428Ser (rs8192678) polymorphism with potential for athletic ability and sports performance: A meta-analysis.

Authors:  Phuntila Tharabenjasin; Noel Pabalan; Hamdi Jarjanazi
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

2.  Association of the ACTN3 R577X (rs1815739) polymorphism with elite power sports: A meta-analysis.

Authors:  Phuntila Tharabenjasin; Noel Pabalan; Hamdi Jarjanazi
Journal:  PLoS One       Date:  2019-05-30       Impact factor: 3.240

3.  Meta-analyses of the association between the PPARGC1A Gly482Ser polymorphism and athletic performance.

Authors:  Ying Chen; Dongmei Wang; Pingping Yan; Shenglan Yan; Qing Chang; Zhi Cheng
Journal:  Biol Sport       Date:  2019-10-10       Impact factor: 2.806

4.  Pilot Study on Genetic Associations With Age-Related Sarcopenia.

Authors:  Felicita Urzi; Boštjan Pokorny; Elena Buzan
Journal:  Front Genet       Date:  2021-01-11       Impact factor: 4.599

5.  FAAH rs324420 Polymorphism Is Associated with Performance in Elite Rink-Hockey Players.

Authors:  Hugo-Henrique Silva; Valéria Tavares; Maria-Raquel G Silva; Beatriz Vieira Neto; Fátima Cerqueira; Rui Medeiros
Journal:  Biology (Basel)       Date:  2022-07-20

6.  Genetic profiles to identify talents in elite endurance athletes and professional football players.

Authors:  David Varillas-Delgado; Esther Morencos; Jorge Gutiérrez-Hellín; Millán Aguilar-Navarro; Alejandro Muñoz; Nuria Mendoza Láiz; Teresa Perucho; Antonio Maestro; Juan José Tellería-Orriols
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

Review 7.  Association of Elite Sports Status with Gene Variants of Peroxisome Proliferator Activated Receptors and Their Transcriptional Coactivator.

Authors:  Miroslav Petr; Agnieszka Maciejewska-Skrendo; Adam Zajac; Jakub Chycki; Petr Stastny
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.